OBJECTIVE: To investigate the contribution of serum lipids, parameters of glucose metabolism, body composition and cardiovascular ®tness to the variance of several haemostatic risk factors for coronary heart disease (CHD) in obese children and adolescents. SUBJECTS AND MEASUREMENTS: Forty-two healthy, obese children and adolescents (20 male, 22 female, age 12.6 AE 3.2 y; body mass index (BMI), 30.4 AE 5.3 kgam 2 ), were screened for haemostatic and metabolic risk factors for CHD. Thirty-®ve of the participants (18 male, age 13.5 AE 2.9 y; BMI, 29.9 AE 4.5 kgam 2 ; 17 female, age 12.8 AE 2.1 y, BMI, 31.1 AE 5.3 kgam 2 ) were assessed for cardiovascular ®tness by means of incremental cycle ergometer exercise. RESULTS: After adjustment for age, fat mass correlated signi®cantly with plasminogen activator inhibitor-1 antigen (PAI-1-Ag) in boys and girls and factor VIIc only in girls. Children with lower power output ( 2.77 Wakg) showed signi®cantly higher values for factor VIIc, ®brinogen and tissue-type plasminogen activator antigen (tPA-Ag). Neither body composition nor cardiovascular ®tness contributed independently to the variance of the determined haemostatic risk factors, except PAI-1-Ag, which has been shown to be determined by fat mass. In multiple linear regression analysis, triglycerides and PAI-1-Ag explained signi®cant independent proportions of the variance of tPA-Ag. Factor VIIc was explained by C-peptide, insulin and ®brinogen. Von Willebrand factor antigen (vWF-Ag) was signi®cantly related to glucose and insulin. CONCLUSION: The results suggest that in obese children and adolescents the haemostatic risk factors factor VIIc, vWF-Ag and tPA-Ag are mainly determinated by plasma insulin and triglyceride concentrations, but are primarily independent of body composition and cardiovascular ®tness.
Introduction
Obesity is associated with non-insulin-dependent diabetes mellitus and cardiovascular disease through the promotion of metabolic and haemostatic abnormalities. 1 ± 4 It has been shown that insulin resistance already exists in preadolescent obese children, 5 suggesting that obesity in childhood lays the metabolic groundwork for adult coronary heart disease (CHD). 6 The Bogalusa Heart Study demonstrated that overweight and dyslipidaemia are linked to the development of atherosclerotic lesions in even paediatric patients. 7 Beside metabolic disturbances, epidemiological evidence indicates that several markers of the haemostatic and ®brinolytic system, which have been shown to be increased in obesity, 8 are potent predictors of the risk for both myocardial infarction and stroke. Impaired ®brinolysis was found to predict future rates of cardiovascular morbidity and mortality. 9 ± 11 In the Northwick Park Heart Study, both the levels of factor VII coagulant activity and plasma ®brinogen were associated with an increased risk of non-fatal myocardial infarction and ischaemic heart disease death among middle-aged men. 12 Additional haemostatic markers for arterial thrombosis comprise increased plasma levels of factor VIII and von Willebrand factor. 13 Haemostatic and metabolic risk factors for CHD are closely associated, and it has been suggested that such a relation is largely mediated by alterations in plasma triglyceride and insulin concentrations. 14 Beside metabolic parameters, physical activity and cardiovascular ®tness have been shown to signi®cantly in¯uence haemostatic risk factors for CHD in adults. 15 ± 17 To our knowledge, no studies have investigated the relative signi®cance of the most important determinants of haemostatic risk factors in a paediatric study population. Therefore, we assessed the contribution of serum lipids, parameters of glucose metabolism, body composition and cardiovascular ®tness to the variance of several haemostatic risk factors for CHD in obese children and adolescents.
Methods

Subjects
The study comprised 42 obese (body mass index (BMI) above the 85th percentile for age and sex 18 ) children and adolescents (20 male, 22 female) aged 12.6AE 3.2 y. At admission, a medical history and physical examination were done to ensure that the participants were otherwise healthy. All children and adolescents had normal liver and renal function as assessed by standard clinical chemistry analysis. None of the participants were taking medications known to affect lipid metabolism or the coagulation system. Informed consent was obtained from each child and a legal guardian. The study protocol was approved by the investigation review board of the University of Graz, Austria.
Analytical methods
Venous blood samples were taken after an overnight fast between 7.30 and 9.30 am in order to further minimize any effect on haemostatic and ®brinolytic variables through the diurnal rhythm. On the ®rst 3 ± 4 ml blood, lipid analyses were done. Total cholesterol, triglycerides and glucose levels were determined using automated enzymatic methods (Hitachi 937, Roche Diagnostics, Austria). HDL cholesterol and VLDL were determined after precipitation of the lipoproteins by dextran sulphate. LDL cholesterol was calculated using the Friedewald formula. Insulin and C-peptide were assessed by means of RIA (Linco, Research MO, USA).
Blood samples for the measurements of haemostatic parameters were drawn into plastic tubes containing 0.1 M sodium citrate. The plasma was separated by centrifugation at 3000 g at 4 C for 10 min and stored at 770 C. Factor VII coagulant activity (VIIc) and factor VIII coagulant activity (VIIIc) were determined using one-stage clotting assays and de®cient plasmas for factor VII and factor VIII, respectively (Behring, Germany). The plasma level of ®brinogen was assayed by the thrombin time method according to Clauss. 19 Von Willebrand factor antigen (Boehringer, Germany), prothrombin fragment 1 2 (Behring, Germany), tissue-type plasminogen activator antigen and plasminogen activator inhibitor-1 antigen (Kabi, Austria) were determined using commercially available enzyme-linked immuno assay kits.
Body composition
Measurement of body composition was done by means of bioelectrical impedance (BIA Akern-RJL 101aS) with an applied current of 50 kHz. Measurements were done in the fasting state after children had been resting in a supine position for 10 min. 20 Fat-free mass (FFM) was calculated 21 and fat mass (FM) was estimated as the difference between body weight and calculated FFM.
Cardiovascular ®tness
From 42 participants, 35 (18 male, age 13.5 AE 2.9 y, BMI, 29.9 AE 4.5 kgam 2 ; 17 female, age 12.8 AE 2.1 y, BMI, 31.1 AE 5.3 kgam 2 ) were eligible for assessment of cardiovascular ®tness; four refused participation and three participants were too young for cycle ergometer exercise. The nature and the risk of the experimental procedures were explained in detail and written informed consent was obtained. Within one week after the blood sampling and assessment of routine laboratory parameters, participants underwent an incremental cycle ergometer exercise 22 (ECB PRO Ergometer 850, Tunturi, Austria) starting at 35 W and increasing in increments of 10 ± 15 W every minute until voluntary exhaustion. Power output was calculated as Wakg body-weight, and in order to disentangle power output from FM, in Wakg FFM.
Statistics
Data not normally distributed were log 10 transformed (VLDL, triglycerides, glucose, insulin, C-peptide and ®brinogen). Unpaired t-test and analysis of variance were used to compare parameters between groups where appropriate. Correlations between variables of interest were calculated using Pearson's correlation coef®cient and partial correlation was done to adjust for the in¯uence of confounding variables. The independence of variables was tested by multiple regression analysis. The magnitude of signi®cant contribution to the variance of the dependent variable was tested in a stepwise, multiple regression model. The signi®cance level of P-values was set at 5%. Calculations were done using SPSS for Windows (SPSS Inc. Chicago) and WinStat 3.1 (Kalmia Co. Inc.).
Results
The whole study consisted of 42 subjects (20 male, 22 female). BMI was above the 85th percentile for age and sex in all individuals and above the 95th percentile in 38 individuals. The main clinical characteristics and biological parameters are given in Table 1 . In the whole group we found an age-dependent increase of FM (r 0.67, P`0.0001), log VLDL (r 0.39, P 0.007), log triglycerides (r 0.4, r 0.005), log glucose (r 0.46, P 0.002), log insulin (r 0.34, P 0.01), log C-peptide (r 0.48, P 0.001), and plasminogen activator inhibitor-1 antigen (PAI-1-Ag) (r 0.35, P 0.01). Correlations between FM and determined risk factors after adjustment for age are shown in Table 2 . After adjustment for age no correlation was found between FM and log triglycerides, log VLDL, total cholesterol, LDL cholesterol, and HDL cholesterol, tissue-type plasminogen activator antigen (tPA-Ag), log ®brinogen, factor VIII coagulant activity (VIIIc), von Willebrand factor Table 3 . Individuals with lower power output had signi®cantly higher levels of FM, percentage FM, factor VIIc, log ®brinogen, tPA-Ag, log triglycerides, log VLDL, log insulin and log C-peptide, and had lower percentage FFM. After adjustment for age, Pearson's correlation revealed a signi®cant inverse correlation between power output (Wakg body weight) and FM (r 70.67, P 0.0004), percentage FM (r 70.52, P 0.004), log insulin (r 70.6, P 0.001), log C-peptide (r 70.67, P`0.001), log VLDL (r 70.5, P 0.004), factor VIIc (r 70.56, P 0.003), log ®brinogen (r 70.5, P 0.004), and tPA-Ag (r 70.38, P 0.04). Percentage FFM correlated signi®cantly with power output (r 0.76, P`0.0001). When cardiovascular ®tness was disentangled from FM by expressing the power output in Wakg FFM, and patients were divided into two groups by the median again (5.14 Wakg FFM), no differences were found between the groups with respect to the above-mentioned parameters. However, power output was signi®cantly correlated with HDL cholesterol (r 0.4, P`0.05) after adjustment for FM.
Relation between haemostatic and metabolic risk factors
After adjustment for age, factor VIIc was signi®cantly correlated with log insulin, log C-peptide, factor VIIIc (only in girls), and log ®brinogen (Table 4) . After stepwise multiple regression analysis log C-peptide, log insulin and log ®brinogen contributed independently and signi®cantly to the variance of factor VIIc in the whole group (r 2 0.66, P`0.001). tPA-Ag correlated signi®cantly with PAI-1-Ag (r 0.42, P 0.005), log triglycerides (r 0.32, P 0.02) and log ®brinogen (r 0.31, P`0.05), and tended to be correlated with log VLDL (r 0.25, P 0.07) and factor VIIc (r 0.27, P 0.06). In multiple linear regression analysis, PAI-1-Ag and log triglycerides explained independent signi®cant proportions of the variance of tPA-Ag (r 2 0.19, P`0.01). As partially described previously, 23 PAI-1-Ag correlated Haemostatic risk factors in childhood obesity S Gallistl et al signi®cantly with log insulin (r 0.43, P 0.002), log C-peptide (r 0.48, P`0.001), log VLDL (r 0.38, P 0.009), and log triglycerides (r 0.4, P 0.005). After adjustment for FM the correlations between PAI-1-Ag and the determined metabolic parameters did not remain signi®cant. Log ®brinogen correlated signi®cantly with factor VIIc and showed a weak, but not signi®cant relation to log triglycerides (r 0.27, P 0.055). Factor VIIc contributed to 25% of the variance of log ®brinogen (P 0.002). vWF-Ag was signi®cantly related to glucose (r 0.39, P 0.012) and log insulin (r 0.3, P 0.036). After adjustment for FM this correlation remained signi®cant. Factor VIIIc and F1 2 were not correlated with metabolic risk factors.
Discussion
The present study was performed to investigate the contribution of anthropometric and metabolic parameters to the variance of haemostatic risk factors for CHD is obese children and adolescents. Triglycerides, which have been shown to have direct effects on PAI-1 promoter activity, 24 correlated signi®cantly with PAI-1-Ag and tPA-Ag. Cigolini et al demonstrated a correlation between triglycerides and plasma levels of tPA-Ag and PAI-1-Ag in adults with and without liver steatosis, 14 suggesting that this relationship is not restricted to patients with insulin resistance. Recently, Van Harmelen et al described an association between plasma triglycerides and adipose tissue PAI-1 secretion independent of gender and genetic variance. 25 In agreement with the assumption that adipose tissue plays a major role in the regulation of plasma PAI-1 levels, we have demonstrated previously that only FM contributed to the variance in PAI-1-Ag in obese children and adolescents. 23 Recent data suggest that subcutaneous adipose tissue expresses more PAI-1 than visceral adipose tissue, 26 which contradicts the ®nding that the plasma PAI-1 level correlates with visceral but not subcutaneous fat area as assessed by computed tomography. 27 We did not investigate body fat distribution, since computed tomography was no option in our study population and it has been suggested that assessment of the waist-to-hip ratio cannot be uncritically recommended as measure of body fat distribution in children. 28 In contrast to studies done in adults, the relation between factor VIIc and triglycerides did not reach signi®cance (P 0.056) in our study population, which might be due to the small number of investigated children. The correlation coef®cient, however, was similar to the study of Cigolini et al (0.27 vs 0.29).
14 The variance of factor VIIc was best explained by C-peptide and insulin. In agreement with our results, Heywood et al demonstrated insulin to be an independent and signi®cant predictor of factor VIIc in adult patients with non-insulin-dependent diabetes mellitus. 29 The mechanism by which hyperinsulinaemia could contribute to elevated concentrations of factor VIIc is not clear. Probably, elevated levels of haemostatic risk factors are one further feature of the common mechanisms leading to hyperinsulinism and associated disorders.
von Willebrand factor antigen (vWF-Ag) correlated signi®cantly with insulin and glucose, also after adjustment for FM. Previously, we had demonstrated elevated von Willebrand factor concentrations in paediatric patients with insulin-dependent diabetes mellitus without vascular disease, 30, 31 re¯ecting initial endothelial cell dysfunction. 32 Since it has been shown that multiple cardiovascular risk factors can be associated with atherosclerotic lesions even in childhood, 7 we suggest that the observed correlation between insulin and vWF-Ag in the present study might re¯ect initial endothelial alterations. In agreement with out results, in adults suffering from noninsulin-dependent diabetes mellitus an association between the insulin resistance syndrome and vWFAg has been described. 33 Surprisingly, cardiovascular ®tness did not contribute to the variance of haemostatic risk factors, although children with low power output showed signi®cantly higher levels of haemostatic and metabolic risk factors, when power output was expressed in a body weight-dependent manner. This correlation disappeared when power output was disentangled from FM. Several studies have demonstrated improvement of haemostatic risk factors and decreased risk of cardiovascular morbidity and mortality associated with physical activity in adults. 15 ± 17 However, when FM was included in multiple regression analyses, cardiovascular ®tness failed to explain the variation in the levels of some haemostatic risk factors. 34 It is not known whether ®tness exerts an independent effect on the risk factors, beyond its effect in reducing fatness. Recently, Ferguson et al investigated the effects of physical exercise on the haemostatic system of obese children and found no signi®cant changes in the haemostatic variables after a 4 month period of physical training. 35 They found that children with greater initial percentage body fat had greater reductions in haemostatic risk factors from before to after the training, suggesting a main in¯u-ence of FM on haemostatic risk factors in childhood obesity. 36 Exercise and physical activity have not only been shown to be associated with improved body composition and favourable serum lipid and lipoprotein levels but also to enhance muscle glucose uptake 37 and to have the sustained effect of augmenting insulin sensitivity. 38 We suggest that the observed favourable risk pro®le in patients with higher cardiovascular ®tness is largely mediated by concomitant improvement in plasma insulin and triglyceride concentrations. Since the bene®cial effect of physical activity in children is supported by controlled exercise programs, 39 further studies have to elucidate whether and how far physical activity, possibly in combination with diet, might
Haemostatic risk factors in childhood obesity S Gallistl et al contribute to the reduction of metabolic and haemostatic risk factors for CHD in childhood obesity. In summary, our results suggest that in obese children and adolescents the haemostatic risk factors factor VIIc, vWF-Ag and tPA-Ag are mainly determined by plasma insulin and triglyceride concentrations, but are primarily independent of body composition and cardiovascular ®tness.
